Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1985-01-28
1988-09-06
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
530328, 530327, 530329, A61K 39015, C07K 706, C07K 700
Patent
active
047692359
ABSTRACT:
Disclosed are peptides the sequence of which defines an immunodominant epitope from the repetitive immunodominant epitope region of the circumsporozoite (CS) protein of a member of the genus Plasmodium, the sequence of the peptide being shorter in length than the repeating unit of the CS protein.
REFERENCES:
Chemical Abstracts, vol. 101, Abstract No. 208756n, 1984.
Chemical Abstracts, vol. 103, Abstract No. 69446n, 1985.
Chemical Abstracts, vol. 101, Abstract No. 223889b, 1984.
Godson et al., Nature, vol. 305, pp. 29-33, 1983.
Dame et al., Science 228:593, 1984.
Schlesinger et al., Biochemistry 23:5665, 1984.
Coppel et al., Nature 306:751, 1983.
Koenen et al., Nature 311:382, Sep. 27, 1984.
Nussenzweig Victor N.
Schlesinger David H.
Hazel Blondel
New York University
LandOfFree
Immunodominant epitope of the circumsporozoite surface protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunodominant epitope of the circumsporozoite surface protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunodominant epitope of the circumsporozoite surface protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1605964